Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 940.30
+11.10 (1.19%)
At close: Mar 27, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 86.67 billion as of March 27, 2026. Its market cap has increased by 51.35% in one year.
Market Cap
86.67B
Enterprise Value
103.30B
Revenue
47.26B
Ranking
n/a
PE Ratio
16.95
Stock Price
940.30
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 86.67B, an increase of 1,056.53%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 86.67B | 4.44% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 187.32B |
| Eris Lifesciences | 185.11B |
| NATCO Pharma | 174.40B |
| Alembic Pharmaceuticals | 136.44B |
| Alivus Life Sciences | 120.86B |
| Cohance Lifesciences | 117.12B |
| Akums Drugs and Pharmaceuticals | 75.58B |
| Sudeep Pharma | 70.86B |